MSB 8.42% $1.03 mesoblast limited

Ann: Change in substantial holding, page-230

  1. 7,072 Posts.
    lightbulb Created with Sketch. 1307
    1. It's the FDA's fault.
    2. It's Big Pharma's fault.
    3. Further from 2 above, it's specifically Novartis's fault.
    4. It's the insto's fault.
    5. It's Pledge's fault. (Or any poster's name on HC).
    6. It can never be the CEO's fault.





    (I've been following along. I think I capture it all?).
 
watchlist Created with Sketch. Add MSB (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.